Clinical evaluation clinical trials

Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers

This study looks at Charcot-Marie-Tooth disease type 1A (CMT1A) over two years. Researchers want to find better ways to track how the disease changes and predict its future course. They hope to develop tools for future treatment studies.